#induced-infringement
#induced-infringement
[ follow ]
#generic-drugs #supreme-court #patent-law #skinny-label #hatch-waxman #pharmaceuticals #patent-infringement
#supreme-court
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
3 days agoJustices Voice Concern that Upholding CAFC's Hikma 'Skinny Label' Ruling Will Harm Generics Industry
The Supreme Court case examines induced infringement claims related to generic drug marketing and its implications for the pharmaceutical industry.
Intellectual property law
fromPatently-O
1 month agoThe Tinderbox: A Framework for Skinny-Label Inducement Before the Supreme Court
Generic manufacturers' decisions to market cheaper drugs with carved-out patented uses while promoting them as full equivalents raises questions about induced patent infringement liability in method-of-use patents.
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
3 months agoSupreme Court to Review CAFC's Induced Infringement Ruling in Hikma v. Amarin
Supreme Court agreed to review whether generic labeling and public statements can constitute inducement of method-patent infringement for carved-out uses.
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
10 months agoSCOTUS Asks SG for Input on Petition Seeking to Clarify Inducement Under Hatch-Waxman
Hikma argues that the CAFC's ruling threatens generic drug access and deviates from established legal precedent on inducement.
[ Load more ]